Mathai Mammen
CIK 1421050 · EVP, Pharm, R&D · last filed 2024-06-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.90M
Companies
4
Total Filings
63
Lifetime Open-Market Net
-$4.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TXG | Director | 180,259 | $28.84 | $5.20M | -$1.74M | 7 | 2024-06-13 |
| JNJ | EVP, Pharm, R&D | 45,300 | $240.87 | $10.91M | $0 | 2 | 2022-02-17 |
| TBPH | SVP, Research & Development | 288,111 | $16.64 | $4.79M | $0 | 10 | 2016-03-17 |
| Innoviva, Inc. (THRX) Delisted | SVP, Research & Early Clin Dev | 334,040 | $4.06 | $1.36M | -$2.96M | 44 | 2014-08-22 |
Recent Filings · Page 5 of 7
63 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-02-22 | Innoviva, Inc. (THRX) Delisted | Tax (F) | −9,747 | -$180.7K | EDGAR |
| 2012-02-17 | Innoviva, Inc. (THRX) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2011-11-22 | Innoviva, Inc. (THRX) Delisted | Tax (F) | −2,250 | -$50.3K | EDGAR |
| 2011-09-02 | Innoviva, Inc. (THRX) Delisted | Exer (M) | +3,225 | $27.5K | EDGAR |
| 2011-08-24 | Innoviva, Inc. (THRX) Delisted | Tax (F) | −2,248 | -$39.3K | EDGAR |
| 2011-05-24 | Innoviva, Inc. (THRX) Delisted | Tax (F) | −2,245 | -$57.2K | EDGAR |
| 2011-02-23 | Innoviva, Inc. (THRX) Delisted | Mixed | −6,941 | -$158.5K | EDGAR |
| 2011-02-15 | Innoviva, Inc. (THRX) Delisted | Grant (A) | +112,500 | $0 | EDGAR |
| 2011-01-28 | Innoviva, Inc. (THRX) Delisted | Exer (M) | +9,838 | $83.9K | EDGAR |
| 2010-11-23 | Innoviva, Inc. (THRX) Delisted | Tax (F) | −2,532 | -$57.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.